Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4 (original) (raw)
Prediction of kinase inhibitor response using activity profiling, in vitro screening, and elastic net regression
Carlo Piermarocchi
BMC Systems Biology, 2014
View PDFchevron_right
Integrated Single-Dose Kinome Profiling Data is Predictive of Cancer Cell Line Sensitivity to Kinase Inhibitors
Chinmaya Joisa
bioRxiv (Cold Spring Harbor Laboratory), 2022
View PDFchevron_right
A quantitative analysis of kinase inhibitor selectivity
Hitesh Patel
Nature biotechnology, 2008
View PDFchevron_right
Structure-Based Kinase Profiling To Understand the Polypharmacological Behavior of Therapeutic Molecules
Devawati Dutta
Journal of chemical information and modeling, 2018
View PDFchevron_right
Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluation
Awwad Radwan
PloS one, 2024
View PDFchevron_right
Structural Bioinformatics-Based Design of Selective, Irreversible Kinase Inhibitors
Chao Zhang
Science, 2005
View PDFchevron_right
Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways
Bhagwan Yadav
PLoS Computational Biology, 2013
View PDFchevron_right
Knowledge Based Prediction of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery
Arup Ghose
Journal of Medicinal Chemistry, 2008
View PDFchevron_right
ChemInform Abstract: Knowledge Based Prediction of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery
Arup Ghose
ChemInform, 2008
View PDFchevron_right
The target landscape of clinical kinase drugs
Robert Preissner
Science (New York, N.Y.), 2017
View PDFchevron_right
Making Sense of Large-Scale Kinase Inhibitor Bioactivity Data Sets: A Comparative and Integrative Analysis
Sushil Shakyawar
Journal of Chemical Information and Modeling, 2014
View PDFchevron_right
Kinome-centric pharmacoproteomics identifies signaling pathways underlying cellular responses to targeted cancer drugs
Venkata Narayana Vidadala
2019
View PDFchevron_right
A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
Chris Joslyn, Landon Whitby
Nature Chemical Biology, 2014
View PDFchevron_right
PKIDB: A Curated, Annotated and Updated Database of Protein Kinase Inhibitors in Clinical Trials
Stéphane Bourg
Molecules (Basel, Switzerland), 2018
View PDFchevron_right
Kinase Inhibitor Profiling Reveals Unexpected Opportunities to Inhibit Disease-Associated Mutant Kinases
Shuguang Liang
Cell Reports, 2016
View PDFchevron_right
Integrating Ligand-Based and Protein-Centric Virtual Screening of Kinase Inhibitors Using Ensembles of Multiple Protein Kinase Genes and Conformations
Gennady Verkhivker
Journal of Chemical Information and Modeling, 2012
View PDFchevron_right
Predictive Models for Fast and Effective Profiling of Kinase Inhibitors
IOnel Ciucanu
Journal of chemical information and modeling, 2016
View PDFchevron_right
KIDFamMap: a database of kinase-inhibitor-disease family maps for kinase inhibitor selectivity and binding mechanisms
Jhang-wei Huang
Nucleic Acids Research, 2012
View PDFchevron_right
Comprehensive transcriptomic analysis of molecularly targeted drugs in cancer for target pathway evaluation
Hiroyuki Seimiya
Cancer Science, 2015
View PDFchevron_right
Virtual Target Screening: Validation Using Kinase Inhibitors
daniel santiago
2012
View PDFchevron_right
Evaluating the Predictivity of Virtual Screening for Abl Kinase Inhibitors to Hinder Drug Resistance
Dilip Narayanan
Chemical Biology & Drug Design, 2013
View PDFchevron_right
Anti-Cancer Drugs Targeting Protein Kinases Approved by FDA in 2020
Jonas Cicenas
Cancers, 2021
View PDFchevron_right
Kinase inhibitors: look beyond the label on the bottle
Cancer Drug Resistance
Cancer Drug Resistance, 2019
View PDFchevron_right
Inverse In Silico Screening for Identification of Kinase Inhibitor Targets
Angelika Vollmar
Chemistry & Biology, 2007
View PDFchevron_right
Rapid Structure-Activity and Selectivity Analysis of Kinase Inhibitors by BioMAP Analysis In Complex Human Primary Cell-Based Models
Ivan Plavec
Assay and drug …, 2004
View PDFchevron_right
Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds
Enrico V. Avvedimento
Oncotarget, 2014
View PDFchevron_right
Redesigning Kinase Inhibitors to Enhance Specificity
Ariel Fernandez
Journal of Medicinal Chemistry, 2008
View PDFchevron_right